STAT

Opinion: Cost-cutting jeopardizes many Americans’ access to lifesaving oxygen therapy

We wouldn't tolerate a pharmacy failing to provide prescribed medication. We shouldn't tolerate companies failing to deliver prescribed oxygen therapy, though it happens all the time.
Source: MANDEL NGAN/AFP/Getty Images

What could a fit mountaineer scaling the world’s tallest peak possibly have in common with an obese store clerk living at sea level? Both need equipment that can deliver extra oxygen but may have trouble getting it.

The New York Times recently published a harrowing story detailing how oxygen suppliers on Mount Everest have put climbers at risk by cutting costs to maximize profits. Some climbers have been harmed — the exact number is unknown — and some may have died due to a lack of oxygen.

A similar problem is occurring

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A 486% Drug Price Hike, AstraZeneca CEO Pay, And More
Is there any circumstance when a 486% increase for a medicine might be justified? A small company called Harrow argues the case for an injectable eye treatment.
STAT1 min read
Disparities In Donor Acceptance Rates Point To Need For More Equitable Heart Transplant Care
While access to donor hearts has increased, there are still gender- and race-based disparities in the acceptance rate of a donor heart offer by transplant teams, a new study finds.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.

Related Books & Audiobooks